Ying Zhou

11PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Molecular targetsGenome structure and regulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 12, 2026
Circular RNA MCM3 recruits USP49 to stabilize PTBP1 and promote cisplatin resistance in cervical squamous cell carcinoma.

|Apr 09, 2026
The 2023 FIGO staging system in uterine serous carcinoma: Exploring prognostic utility and molecular characterization.

Jiang Meng, Li Ge, Xiaoli Wang

|Feb 12, 2026
Ascites circRNA ASCOR Drives Platinum Resistance of High-Grade Serous Ovarian Cancer by Facilitating RPA1 Nuclear Translocation.

Hanyuan Liu, Chenchen Zhu, Xuelin Yao

|Nov 26, 2025
The H3K27me3 reader UAD-2 recruits a TAF-12-containing transcription machinery to initiate piRNA expression within heterochromatic clusters.

Xinya Huang, Yan Kuang, Meili Li

|Jun 10, 2025
Tumor Small Extracellular Vesicle-Transmitted LncRNA CATED Promotes Platinum-Resistance in High-Grade Serous Ovarian Cancer.

Yi Liu, Hanyuan Liu, Chenchen Zhu

|May 02, 2025
piRNA gene density and SUMOylation organize piRNA transcriptional condensate formation.

Chengming Zhu, Xiaoyue Si, Xinhao Hou

Pageof 2

Frequent Collaborators

3 joint publications

Hanyuan Liu

3 joint publications

Liang Chen

3 joint publications

Ge Shan

2 joint publications

Shouhong Guang